New alternatives for protocols with murine models of asthma [Abstract in English]

Detalhes bibliográficos
Autor(a) principal: Parreira, Camila
Data de Publicação: 2012
Outros Autores: Rodrigues, Andrea Mendonça, Gualdi, Lucien Peroni, Cao, Raquel Giacomelli, de Souza, Rodrigo Godinho, Pereira, Ana Cláudia, Nuñez, Nailê Karine, Schleich, Alisson, Vargas, Mauro Henrique, Pitrez, Paulo Márcio
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Scientia Medica (Porto Alegre. Online)
Texto Completo: https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785
Resumo: AIMS: To test alternative protocols using animal models of acute and chronic asthma, with features closer to human disease, using ovalbumin without adjuvant. METHODS: Adult female BALB/c mice were used and divided into groups according to sensitization with ovalbumin. The acute model used two doses of ovalbumin subcutaneously without adjuvant, on days 0 and 7, and after intranasal challenge for consecutives three days, compared with a standard protocol using three doses of ovalbumin for sensitization. The chronic model also used ovalbumin subcutaneously for sensitization, adjuvant-free, on days 0 and 14, and after intranasal challenge, for eight consecutive weeks. Total and differential cell counts from bronchoalveolar lavage and histopathology of the lungs were performed 24 hours after the last ovalbumin challenge. RESULTS: In both models of protocols studied, acute and chronic, we have observed similar allergic pulmonary response between the groups. Cell counts and histological analysis of lung tissue showed no significant difference between groups. CONCLUSIONS: Use of sensitization in murine model with ovalbumin subcutaneously, with no adjuvant (alum), resulted in an expected allergic pulmonary response, with predominant eosinophils. These protocols may be a future option to animal models of asthma closer to the human disease, both in the acute and chronic patterns.
id PUC_RS-25_3c3a1c94459dd2d1b2c7709a8c37fbc6
oai_identifier_str oai:ojs.revistaseletronicas.pucrs.br:article/10785
network_acronym_str PUC_RS-25
network_name_str Scientia Medica (Porto Alegre. Online)
repository_id_str
spelling New alternatives for protocols with murine models of asthma [Abstract in English]Novas alternativas para protocolos com modelos murinos de asmaASTHMAALLERGYMICEOVALBUMINANIMALMODELS.ASMAALERGIACAMUNDONGOSOVALBUMINAMODELOS ANIMAIS.AIMS: To test alternative protocols using animal models of acute and chronic asthma, with features closer to human disease, using ovalbumin without adjuvant. METHODS: Adult female BALB/c mice were used and divided into groups according to sensitization with ovalbumin. The acute model used two doses of ovalbumin subcutaneously without adjuvant, on days 0 and 7, and after intranasal challenge for consecutives three days, compared with a standard protocol using three doses of ovalbumin for sensitization. The chronic model also used ovalbumin subcutaneously for sensitization, adjuvant-free, on days 0 and 14, and after intranasal challenge, for eight consecutive weeks. Total and differential cell counts from bronchoalveolar lavage and histopathology of the lungs were performed 24 hours after the last ovalbumin challenge. RESULTS: In both models of protocols studied, acute and chronic, we have observed similar allergic pulmonary response between the groups. Cell counts and histological analysis of lung tissue showed no significant difference between groups. CONCLUSIONS: Use of sensitization in murine model with ovalbumin subcutaneously, with no adjuvant (alum), resulted in an expected allergic pulmonary response, with predominant eosinophils. These protocols may be a future option to animal models of asthma closer to the human disease, both in the acute and chronic patterns.OBJETIVOS: Testar alternativas de protocolos com modelos animais de asma aguda e crônica que apresentem características mais próximas da doença em humanos, utilizando ovalbumina livre de adjuvante. MÉTODOS: Foram utilizadas fêmeas adultas de camundongos BALB/c, divididas em grupos de acordo com as sensibilizações com ovalbumina. O modelo agudo utilizou duas doses de ovalbumina subcutânea, sem adjuvante, com intervalo de sete dias, com posterior desafio intranasal durante três dias, comparado ao protocolo padrão que utiliza três doses de ovalbumina intraperitoneal, no período de sensibilização. O modelo crônico também utilizou ovalbumina subcutânea livre de adjuvante para sensibilização, com intervalo de 14 dias e posterior desafio intranasal, três vezes por semana, durante oito semanas. Contagem total e diferencial de células no lavado broncoalveolar e análise histológica dos pulmões foram realizadas 24 horas após o último desafio com ovalbumina. RESULTADOS: Nos dois modelos estudados, agudo e crônico, observou-se uma resposta eosinofílica pulmonar semelhante entre os grupos. A contagem de células e a análise histológica do tecido pulmonar não apresentaram diferença significativa entre os grupos estudados. CONCLUSÕES: O uso de sensibilização subcutânea em modelo murino com ovalbumina, sem adjuvante (alum), resulta em significativa resposta inflamatória pulmonar alérgica, com predomínio de eosinófilos, podendo ser uma opção futura para experimentos mais próximos ao modelo humano, tanto na fase aguda, como na fase crônica da doença.Editora da PUCRS - ediPUCRS2012-07-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785Scientia Medica; Vol. 22 No. 2 (2012); 71-80Scientia Medica; v. 22 n. 2 (2012); 71-801980-61081806-5562reponame:Scientia Medica (Porto Alegre. Online)instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)instacron:PUC_RSporenghttps://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785/8153https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785/8154Parreira, CamilaRodrigues, Andrea MendonçaGualdi, Lucien PeroniCao, Raquel Giacomellide Souza, Rodrigo GodinhoPereira, Ana CláudiaNuñez, Nailê KarineSchleich, AlissonVargas, Mauro HenriquePitrez, Paulo Márcioinfo:eu-repo/semantics/openAccess2013-07-15T18:44:36Zoai:ojs.revistaseletronicas.pucrs.br:article/10785Revistahttps://revistaseletronicas.pucrs.br/scientiamedica/PUBhttps://revistaseletronicas.pucrs.br/scientiamedica/oaiscientiamedica@pucrs.br || editora.periodicos@pucrs.br1980-61081806-5562opendoar:2013-07-15T18:44:36Scientia Medica (Porto Alegre. Online) - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)false
dc.title.none.fl_str_mv New alternatives for protocols with murine models of asthma [Abstract in English]
Novas alternativas para protocolos com modelos murinos de asma
title New alternatives for protocols with murine models of asthma [Abstract in English]
spellingShingle New alternatives for protocols with murine models of asthma [Abstract in English]
Parreira, Camila
ASTHMA
ALLERGY
MICE
OVALBUMIN
ANIMAL
MODELS.
ASMA
ALERGIA
CAMUNDONGOS
OVALBUMINA
MODELOS ANIMAIS.
title_short New alternatives for protocols with murine models of asthma [Abstract in English]
title_full New alternatives for protocols with murine models of asthma [Abstract in English]
title_fullStr New alternatives for protocols with murine models of asthma [Abstract in English]
title_full_unstemmed New alternatives for protocols with murine models of asthma [Abstract in English]
title_sort New alternatives for protocols with murine models of asthma [Abstract in English]
author Parreira, Camila
author_facet Parreira, Camila
Rodrigues, Andrea Mendonça
Gualdi, Lucien Peroni
Cao, Raquel Giacomelli
de Souza, Rodrigo Godinho
Pereira, Ana Cláudia
Nuñez, Nailê Karine
Schleich, Alisson
Vargas, Mauro Henrique
Pitrez, Paulo Márcio
author_role author
author2 Rodrigues, Andrea Mendonça
Gualdi, Lucien Peroni
Cao, Raquel Giacomelli
de Souza, Rodrigo Godinho
Pereira, Ana Cláudia
Nuñez, Nailê Karine
Schleich, Alisson
Vargas, Mauro Henrique
Pitrez, Paulo Márcio
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Parreira, Camila
Rodrigues, Andrea Mendonça
Gualdi, Lucien Peroni
Cao, Raquel Giacomelli
de Souza, Rodrigo Godinho
Pereira, Ana Cláudia
Nuñez, Nailê Karine
Schleich, Alisson
Vargas, Mauro Henrique
Pitrez, Paulo Márcio
dc.subject.por.fl_str_mv ASTHMA
ALLERGY
MICE
OVALBUMIN
ANIMAL
MODELS.
ASMA
ALERGIA
CAMUNDONGOS
OVALBUMINA
MODELOS ANIMAIS.
topic ASTHMA
ALLERGY
MICE
OVALBUMIN
ANIMAL
MODELS.
ASMA
ALERGIA
CAMUNDONGOS
OVALBUMINA
MODELOS ANIMAIS.
description AIMS: To test alternative protocols using animal models of acute and chronic asthma, with features closer to human disease, using ovalbumin without adjuvant. METHODS: Adult female BALB/c mice were used and divided into groups according to sensitization with ovalbumin. The acute model used two doses of ovalbumin subcutaneously without adjuvant, on days 0 and 7, and after intranasal challenge for consecutives three days, compared with a standard protocol using three doses of ovalbumin for sensitization. The chronic model also used ovalbumin subcutaneously for sensitization, adjuvant-free, on days 0 and 14, and after intranasal challenge, for eight consecutive weeks. Total and differential cell counts from bronchoalveolar lavage and histopathology of the lungs were performed 24 hours after the last ovalbumin challenge. RESULTS: In both models of protocols studied, acute and chronic, we have observed similar allergic pulmonary response between the groups. Cell counts and histological analysis of lung tissue showed no significant difference between groups. CONCLUSIONS: Use of sensitization in murine model with ovalbumin subcutaneously, with no adjuvant (alum), resulted in an expected allergic pulmonary response, with predominant eosinophils. These protocols may be a future option to animal models of asthma closer to the human disease, both in the acute and chronic patterns.
publishDate 2012
dc.date.none.fl_str_mv 2012-07-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785
url https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785/8153
https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10785/8154
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Editora da PUCRS - ediPUCRS
publisher.none.fl_str_mv Editora da PUCRS - ediPUCRS
dc.source.none.fl_str_mv Scientia Medica; Vol. 22 No. 2 (2012); 71-80
Scientia Medica; v. 22 n. 2 (2012); 71-80
1980-6108
1806-5562
reponame:Scientia Medica (Porto Alegre. Online)
instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron:PUC_RS
instname_str Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron_str PUC_RS
institution PUC_RS
reponame_str Scientia Medica (Porto Alegre. Online)
collection Scientia Medica (Porto Alegre. Online)
repository.name.fl_str_mv Scientia Medica (Porto Alegre. Online) - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
repository.mail.fl_str_mv scientiamedica@pucrs.br || editora.periodicos@pucrs.br
_version_ 1809101749625028608